Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications

Summary

To identify adverse effects of ovulation drugs on pregnancy, including pregnancy loss, fetal teratology and dysmorphology, and infant development up to age 3.

Conditions

• Infertility

Sponsors & Collaborators

• Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

  collaborator NIH

• Penn State University

  collaborator OTHER

• University of Colorado, Denver

  collaborator OTHER

• University of Michigan

  collaborator OTHER

• University of Pennsylvania

  collaborator OTHER

• University of Texas

  collaborator OTHER

• University of Vermont

  collaborator OTHER

• Wayne State University

  collaborator OTHER

• Yale University

  lead OTHER

Principal Investigators

• Esther Eisenberg, MD, MPH · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

• Nanette Santoro, MD · Albert Einstein College of Medicine

• Richard Legro, MD · Pennsylvania State University College of Medicine

• Robert Brzyski, MD, PhD · The University of Texas Health Science Center at San Antonio

• Peter Casson, MD · University of Vermont

• Michael Diamond, MD · Wayne State University

• Heping Zhang, PhD · Yale University

• Gregory Christman, MD · University of Michigan

• Christos Coutifaris, MD · University of Pennsylvania

• William Schlaff, MD · University of Colorado Denver Health Science Center

Eligibility

Min Age

18 Years

Max Age

40 Years

Sex

FEMALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2009-05-31

Primary Completion

2014-06-27

Completion

2014-06-27

Countries

• United States

Study Locations